Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (34)
Anita van Eck van der Sluijs, Pearl Pai, Wenjuan Zhu & Gurbey Ocak. (2024) Bleeding Risk in Hemodialysis Patients. Seminars in Nephrology, pages 151478.
Crossref
Crossref
Abbas Saroukhani & Mild Golshani Nasab. (2021) A Randomized Clinical Trial of Low-dose Warfarin Therapy for Improving the Longevity of Permanent Arteriovenous Catheters. Annals of Vascular Surgery 73, pages 165-170.
Crossref
Crossref
Qi Wang, Xiaojie Xie & Gaosi Xu. (2020) The risk of bleeding for antiplatelet agents in Haemodialysis patients: a Meta-analysis. BMC Nephrology 21:1.
Crossref
Crossref
Bryan Khai D. Ngo, Kendrick K. Lim, Jessica C. Johnson, Abhishek Jain & Melissa A. Grunlan. (2020) Thromboresistance of Polyurethanes Modified with PEO‐Silane Amphiphiles. Macromolecular Bioscience 20:12.
Crossref
Crossref
Bryan Khai D. Ngo, Mikayla E. Barry, Kendrick K. Lim, Jessica C. Johnson, David J. Luna, Navaneeth K.R. Pandian, Abhishek Jain & Melissa A. Grunlan. (2020) Thromboresistance of Silicones Modified with PEO-Silane Amphiphiles. ACS Biomaterials Science & Engineering 6:4, pages 2029-2037.
Crossref
Crossref
Mandeep S. Randhawa, Rohanlal Vishwanath, Manoj P. Rai, Ling Wang, Amritpal K. Randhawa, George Abela & Gaurav Dhar. (2020) Association Between Use of Warfarin for Atrial Fibrillation and Outcomes Among Patients With End-Stage Renal Disease. JAMA Network Open 3:4, pages e202175.
Crossref
Crossref
Bryan Khai D. Ngo, Kendrick K. Lim, Shane J. Stafslien & Melissa A. Grunlan. (2019) Stability of silicones modified with PEO-silane amphiphiles: Impact of structure and concentration. Polymer Degradation and Stability 163, pages 136-142.
Crossref
Crossref
Eslam Samaha, Michael Schwameis, Sabine Schranz, Bruno Watschinger, Anja Buchmüller & Bernd Jilma. (2019)
Acetylsalicylic acid decreases clotting in combination with enoxaparin during haemodialysis
in vitro
. Nephrology Dialysis Transplantation 34:3, pages 509-515.
Crossref
Crossref
Cathy E. Langston & Adam E. Eatroff. (2018) Hemodialysis catheter‐associated fibrin sheath in a dog. Journal of Veterinary Emergency and Critical Care 28:4, pages 366-371.
Crossref
Crossref
Mohamad Mozafar, Majid Alborzi & Arash Moradi. (2018) Effects of Clopidogrel on Longevity of Permanent Double-Lumen Catheter Patency in Dialysis Patients: A Single-Blind Placebo-Controlled Clinical Trial. Nephro-Urology Monthly 10:2.
Crossref
Crossref
Maurizio Gallieni, Antonino Giordano, Umberto Rossi & Maurizio Cariati. (2016) Optimization of Dialysis Catheter Function. The Journal of Vascular Access 17:1_suppl, pages S42-S46.
Crossref
Crossref
Lihua Wang, Fang Wei, Aili Jiang, Haiyan Chen, Guijiang Sun & Xueqing Bi. (2015) Longer duration of catheter patency, but similar infection rates with internal jugular vein versus iliac vein tunneled cuffed hemodialysis catheters: a single-center retrospective analysis. International Urology and Nephrology 47:10, pages 1727-1734.
Crossref
Crossref
Jingzhen Li, Lijuan Wang, Jinzhu Hu & Gaosi Xu. (2015) Warfarin use and the risks of stroke and bleeding in hemodialysis patients with atrial fibrillation: A systematic review and a meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases 25:8, pages 706-713.
Crossref
Crossref
Mohammad Mozafar, Majid Samsami, Mohammad Reza Sobhiyeh, Sayena Jabbehdari & Mahtab Fallah Zavareh. (2013) Effectiveness of Aspirin on Double Lumen Permanent Catheter Efficacy in ESRD. Nephro-Urology Monthly 5:2, pages 762-5.
Crossref
Crossref
Ladan Golestaneh & Michele H. Mokrzycki. (2013) Vascular access in therapeutic apheresis: Update 2013. Journal of Clinical Apheresis 28:1, pages 64-72.
Crossref
Crossref
Marek Saracyn, Dorota Brodowska-Kania & Stanisław Niemczyk. (2013) Oral Anticoagulant Therapy in Patients Receiving Haemodialysis: Is It Time to Abandon It?. The Scientific World Journal 2013, pages 1-9.
Crossref
Crossref
Timmy Lee, Charmaine Lok, Miguel Vazquez, Louise Moist, Ivan Maya & Michele Mokrzycki. (2012) Minimizing Hemodialysis Catheter Dysfunction: An Ounce of Prevention. International Journal of Nephrology 2012, pages 1-10.
Crossref
Crossref
Gabriele Donati, Luigi Colì, Giuseppe Cianciolo, Gaetano La Manna, Vania Cuna, Mara Montanari, Francesco Gozzetti & Sergio Stefoni. (2011) Thrombosis of Tunneled‐Cuffed Hemodialysis Catheters: Treatment With High‐Dose Urokinase Lock Therapy. Artificial Organs 36:1, pages 21-28.
Crossref
Crossref
Trevor J. Wilkieson, Alistair J. Ingram, Mark A. Crowther, Steven D. Soroka, Ryuta Nagai, Kailash K. Jindal & Catherine M. Clase. (2011) Low-Intensity Adjusted-Dose Warfarin for the Prevention of Hemodialysis Catheter Failure. Clinical Journal of the American Society of Nephrology 6:5, pages 1018-1024.
Crossref
Crossref
Ricarda Marinigh, Deirdre A. Lane & Gregory Y.H. Lip. (2011) Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation. Journal of the American College of Cardiology 57:12, pages 1339-1348.
Crossref
Crossref
Richard Fluck & Mick Kumwenda. (2011) Renal Association Clinical Practice Guideline on Vascular Access for Haemodialysis. Nephron Clinical Practice 118:s1, pages c225-c240.
Crossref
Crossref
Jeremías Bayón, María Martín, José Manuel García-Ruíz & Carmen Rodríguez. (2010) “We have a tenant” a right atrial thrombus related to a central catheter. The International Journal of Cardiovascular Imaging 27:1, pages 5-6.
Crossref
Crossref
Michele H. Mokrzycki & Charmaine E. Lok. (2010) Traditional and non-traditional strategies to optimize catheter function: go with more flow. Kidney International 78:12, pages 1218-1231.
Crossref
Crossref
Hasan H. Dosluoglu & Linda M. Harris. 2010. Rutherford's Vascular Surgery. Rutherford's Vascular Surgery
1137
1154
.
Guido Finazzi & Giulio Mingardi. (2009) Oral anticoagulant therapy in hemodialysis patients: do the benefits outweigh the risks?. Internal and Emergency Medicine 4:5, pages 375-380.
Crossref
Crossref
Swapnil Hiremath, Rachel M. Holden, Dean Fergusson & Deborah L. Zimmerman. (2009) Antiplatelet Medications in Hemodialysis Patients. Clinical Journal of the American Society of Nephrology 4:8, pages 1347-1355.
Crossref
Crossref
Guillaume Jean, Thierry Vanel, Éric Bresson, Jean-Claude Terrat, Jean-Marc Hurot, Christie Lorriaux, Brice Mayor & Charles Chazot. (2009) Une stratégie efficace pour diminuer l’utilisation et les complications des cathéters veineux centraux tunnelisés en hémodialyse. Néphrologie & Thérapeutique 5:4, pages 280-286.
Crossref
Crossref
Román Martínez-Cercós, Andreu Foraster, Jesús Cebollada, Rafael Álvarez-Lipe, Ángel Sánchez-Casajús & Emilio Sánchez Casado. (2008) Consensos accesos vasculares para hemodiálisis. Diálisis y Trasplante 29:4, pages 226-235.
Crossref
Crossref
Lisa Willms & Lavern M. Vercaigne. (2007)
Review
: Does Warfarin Safely Prevent Clotting of Hemodialysis Catheters?
. Seminars in Dialysis 21:1, pages 71-77.
Crossref
Crossref
Meghan J. Elliott, Deborah Zimmerman & Rachel M. Holden. (2007) Warfarin Anticoagulation in Hemodialysis Patients: A Systematic Review of Bleeding Rates. American Journal of Kidney Diseases 50:3, pages 433-440.
Crossref
Crossref
Ibrahiem Saeed Abdul-Rahman & Abdulla K. Al-Howaish. (2007) Warfarin Versus Aspirin in Preventing Tunneled Hemodialysis Catheter Thrombosis: A Prospective Randomized Study. Hong Kong Journal of Nephrology 9:1, pages 23-30.
Crossref
Crossref
ANIL K SAXENA, BODH R PANHOTRA, DASAPPAN S SUNDARAM, MOHAMMED NAGUIB FAHMY MORSY & ALI M AL‐ARABI AL‐GHAMDI. (2006) Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: A randomised, double‐blind clinical trial. Nephrology 11:4, pages 299-305.
Crossref
Crossref
P. Brunet, V. Faure, V. Moal & Y. Berland. (2006) Troubles de l'hémostase au cours de l'insuffisance rénale chronique. EMC - Néphrologie 1:1, pages 1-7.
Crossref
Crossref
Michael J. Flanigan. (2005) Melagatran anticoagulation during haemodialysis—‘Primum non nocere’. Nephrology Dialysis Transplantation 20:9, pages 1789-1790.
Crossref
Crossref